BioSpace News Archive

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2022 before the market open on Thursday, April 7, 2022.

Cano Health, Inc., a leading value-based primary care provider and population health company, announced financial results for the fourth quarter and full year ended December 31, 2021.

Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported financial results for the fourth quarter and full year ended December 31, 2021 as well as certain other business highlights.

Illumina, Inc. announced that Carissa Rollins will join the company as Chief Information Officer on March 14, 2022.

VBL Therapeutics today announced that it will release financial results for the year ended December 31, 2021 on Wednesday, March 23 before market open.

Increasing prevalence of cancer and reproductive health disorders and evolution of cutting-edge next-generation sequencing (NGS) platforms are among the key factors expected to drive the global market revenue growth.

The global behavioral health market size is expected to be worth around US$ 242 billion by 2027 and poised to grow at a CAGR of 5.02% over the forecast period 2021 to 2027.

According to Precedence Research, the global clinical workflow solutions market size is expected to reach around US$ 23.99 billion by 2030 from valued at USD 8.26 billion in 2021 with a CAGR of 12.6% from 2021 to 2030.

The global continuous glucose monitoring device market was estimated at USD 4.7 billion in 2021 and is expected to reach over USD 10.34 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 9.2% during the forecast period 2021 to 2030.

According to Precedence Research, the corporate wellness market is expected to reach valuation US$ 96.15 billion by 2030 and growing at a CAGR of 6.9% from 2021 to 2030.